ยินดีต้อนรับกลับมา
เข้าร่วม CoinTime
เข้าสู่ระบบ email
สร้างบัญชี email
ตรวจสอบกล่องจดหมายของคุณ
Stämm Biotech
About
Stämm is downsizing a whole biotech facility into an all-in-one, pug-n-play desktop unit called The Bioprocessor.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $17M
- Industries
- Biotechnology,Information Technology,Life Science
- Founded date
- Jan 1, 2014
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Stämm Biotech specializes in life sciences. During the past two years, Stämm has designed a novel bioproduction system that leverages microfluidics, electroporation and robotics to solve the main constraint of the biotech industry: scaling up. Solving this problem could unlock a $700B market in the next 10 years.Today, after integrating these state-of-the-art technologies, the company is unveiling the future of biomanufacturing. Stämm downsized a whole biotech facility into an all-in-one, plug-n-play desktop unit: the Bioprocessor, which has proven to be at least 70x more productive than traditional bioreactors.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 28, 2022 | Series A | $17M | 5 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Dragones VC
|
— | Series A |
|
|
— | Series A |
|
|
— | Series A |
|
|
— | Series A |
|
|
— | Series A |
